Syndax Pharmaceuticals Inc (SNDX) FY2025Q1 Earning Prediction

05/05 04:00:00

After Hours

Syndax Pharmaceuticals Inc (SNDX) is set to release its earnings performance on 05/05 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 16.18M and an earnings per share (EPS) of -1.03 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

16.18M

20.04M

+23.87%

EPSBEAT

-1.03

-0.98

+4.85%

AI Summary

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

SNDX Transcript

Syndax Pharmaceuticals, Inc. (SNDX) Presents at UBS Global Healthcare Conference 2025 Transcript

Neutral11-10

Syndax Pharmaceuticals, Inc. (SNDX) Q3 2025 Earnings Call Transcript

Positive11-3

The earnings call summary highlights strong financial performance, product development, and market strategy, with optimistic guidance and shareholder return plans. The Q&A section provides additional positive insights, such as excellent payer access and a consistent safety profile for Revuforj. The strategic plan indicates significant growth opportunities, including market expansion and profitability outlook. Considering the company's strong market position, upcoming product approvals, and positive financial health, the stock is likely to see a positive movement in the short term.

Syndax Pharmaceuticals, Inc. (SNDX) Presents At Citi's Biopharma Back To School Conference Transcript

Neutral9-2

Syndax Pharmaceuticals, Inc. (SNDX) Q2 2025 Earnings Call Transcript

Positive8-4

The earnings call highlights strong revenue growth for both Revuforj and Niktimvo, with positive physician and patient feedback. The company expects profitability with existing resources and stable expenses. The Q&A section provides confidence in FDA approval and market expansion, particularly with the NPM1 label expansion. Although management avoided specific guidance, the overall sentiment is positive with strong financial performance and optimistic future outlooks.

SNDX Slides

Syndax Q3 2025 slides: Strong product growth despite revenue miss, path to profitability

2025-11-03

SNDX Report

Syndax Pharmaceuticals Inc 10-Q

10-Q

2024-11-05

Syndax Pharmaceuticals Inc 10-Q

10-Q

2024-05-08

Syndax Pharmaceuticals Inc 10-K

10-K

2024-02-27

Syndax Pharmaceuticals Inc 10-Q

10-Q

2023-11-02

Frequently Asked Questions

What is the Syndax Pharmaceuticals Inc FY2025Q1 Earnings Release Date and Time?

Syndax Pharmaceuticals Inc (SNDX) is scheduled to release its FY2025Q1 earnings report onMay 5, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Syndax Pharmaceuticals Inc FY2025Q1 Revenue and EPS?

Analysts' consensus predicts 16.18M in revenue and an EPS of -1.03 for Syndax Pharmaceuticals Inc's FY2025Q1.

What Does Intellectia's AI Predict for Syndax Pharmaceuticals Inc FY2025Q1 Earnings?

Intellectia's exclusive AI algorithms forecast a forSyndax Pharmaceuticals Inc's FY2025Q1 earnings, with a prediction date of May 5, 2025. Syndax Pharmaceuticals Inc

How Can I Use This Earnings Prediction to Trade SNDX Stock?

Leverage Intellectia's AI forecast to position trades ahead of theMay 5, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Syndax Pharmaceuticals Inc FY2025Q1?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!